Digital Therapeutics Market Size, Share & Trends Report

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, Smoking Cessation, Respiratory Diseases), By End-use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-768-1
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Digital Therapeutics End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Patients
    • Providers
    • Payers
    • Employers
    • Others
  • Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Diabetes
    • Obesity
    • CVD
    • Respiratory Diseases
    • Smoking Cessation
    • CNS Diseases
    • Others
  • Digital Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Digital Therapeutics Market, By Application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • North America Digital Therapeutics Market, By End-use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      •  U.S
        • U.S. Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • U.S. Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      •  Canada
        • Canada Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Canada Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    •  Europe
      • Europe Digital Therapeutics Market, By Application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Europe Digital Therapeutics Market, By End-use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      •  Germany
        • Germany Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Germany Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      •  UK
        • UK Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • UK Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • France 
        • France Digital Therapeutics Market, By Applications
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • France Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Italy 
        • Italy Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Italy Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Spain 
        • Spain Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Spain Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Denmark 
        • Denmark Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Denmark Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Sweden 
        • Sweden Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Sweden Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Norway
        • Norway Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Norway Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Asia Pacific
      • Asia Pacific Digital Therapeutics Market, By Application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Asia Pacific Digital Therapeutics Market, By End-use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • China
        • China Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • China Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Japan
        • Japan Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Japan Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • India
        • India Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • India Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Australia
        • Australia Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Australia Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • South Korea
        • South Korea Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • South Korea Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Thailand
        • Thailand Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Thailand Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Latin America
      • Latin America Digital Therapeutics Market, By Application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Latin America Digital Therapeutics Market, By End-use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • Brazil
        • Brazil Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Brazil Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Mexico
        • Mexico Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Mexico Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Argentina
        • Argentina Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Argentina Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Middle East & Africa
      • Middle East & Africa Digital Therapeutics Market, By Application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Middle East & Africa Digital Therapeutics Market, By End-use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • South Africa
        • South Africa Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • South Africa Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Saudi Arabia
        • Saudi Arabia Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Saudi Arabia Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • UAE
        • UAE Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • UAE Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Israel
        • Israel Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Israel Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Kuwait
        • Kuwait Digital Therapeutics Market, By Application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Kuwait Digital Therapeutics Market, By End-use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others

Digital Therapeutics Market Dynamics

Driver-Increasing Smartphone Penetration

The percentage of people across the globe using the internet and owning a smartphone is growing rapidly. According to Kepios, as of April 2021, around 4.27 billion people use the internet globally, which is over 60% of the global population. As this number increases, awareness about smart health tracking is expected to improve. With many mHealth wellness apps being available for mobile devices today, it is expected that digital therapeutics can lead to major changes in healthcare delivery. As per Kepios, the number of internet users globally is growing at an annual rate of 7.6%, i.e., an average addition of 900,000 new users every day. While developed and certain developing economies have high smartphone and internet penetration, countries in regions such as Africa and South Asia are lagging due to their less advanced economies. With a modest user base, Africa’s smartphone market is expected to grow due to the advent of affordable handsets in the country. These handsets are priced under USD 100 per unit and are gaining popularity.

Driver-Cost-Effectiveness of Digital Health Technology for Providers and Patients

The need for cost-effective healthcare is increasing due to growing healthcare expenditure. The rising incidence of chronic diseases has led to an increase in healthcare costs. This has affected economic growth in developing and developed economies. To promote cheaper and alternative means of healthcare delivery, digital health technologies are being encouraged to help avoid added costs. The ease of usage of mHealth apps and their consistent performance can help improve health outcomes of individuals and communities, which is anticipated to have a positive impact on the market. Digital health technologies can offer multiple health services to users at affordable prices. Mobile interfaces can enable quick consultations with physicians and doctors at any given place & time. Mobile interfaces have simple design and are easy to use. They provide information on symptoms and medical conditions and facilitate better treatment compliance with high patient satisfaction. From a provider’s standpoint, digital health technology focuses on prevention, facilitates patient independence, and provides better outcomes by reducing hospital admissions & duration of stay.

Restraint-Low Smartphone Penetration in Underdeveloped Countries

The high penetration of smartphones is a major factor influencing demand for digital therapeutics. However, smartphones are more common in Europe and the U.S. than in developing economies, such as Afghanistan, Bangladesh, Central African Republic, and Colombia. The concept of digital healthcare technology is fairly new and ignored due to underlying social factors such as low per capita income and lack of education. Africa and South Asia are key regions where penetration is low. However, several studies highlight a huge range of possibilities offered by mobile- and smartphone-enabled applications & services, once social & economic constraints are reduced or removed. India, Brazil, Kenya, Egypt, Nigeria, and South Africa are examples of countries that are driving smartphone penetration to facilitate better health outcomes. However, low adoption of smartphones and mobile internet can affect market dynamics.

What Does This Report Include?

This section will provide insights into the contents included in this digital therapeutics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Digital therapeutics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Digital therapeutics market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon